ERNA: Ernexa Therapeutics Inc. Common Stock Company Profile & Statistics

About

Ernexa Therapeutics is developing cell therapies for the treatment of advanced cancer and autoimmune disease. Ernexa Therapeutics, formerly known as Eterna Therapeutics, is based in CAMBRIDGE, Mass.

Info & Links

CEO

Sanjeev Luther

Headquarters

1035 CAMBRIDGE STREET, SUITE 18A
CAMBRIDGE, MA 02141, UNITED STATES

Auditor

GRANT THORNTON LLP

Share holders

146

Employees

Ernexa Therapeutics Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

11.93M

Enterprise Value

12.26M

Enterprise Value/EBITDA(ttm)

-1.85

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

23.39

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

2.55%

Operating Margin(ttm)

-7652.75%

Profit Margin(ttm)

-4310.92%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-1499.90%

Return on Assets(ttm)

-285.71%

Income Statement

Revenue(ttm)

535.00K

Revenue Per Share(ttm)

0.13

Gross Profit(ttm)

500.00K

EBITDA(ttm)³

-6.64M

Net Income Available to Common(ttm)

-46.11M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

5.30

52-Week Change

-94.29%

S&P 500 52-Week Change

16.67%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

4.16M

Dividend Yield

0.00%

Float⁴

7.25M

% Held by Insiders

1.50%

% Held by Institutions

70.55%

Balance Sheet

Total Cash(mrq)

1.92M

Total Cash Per Share(mrq)

0.46

Total Debt(mrq)

2.25M

Total Debt/Equity(mrq)

-37.82%

Current Ratio(mrq)

0.21%

Quick Ratio(mrq)

0.21%

Book Value Per Share(mrq)

-1.71

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.58

Free Cash Flow(ytd)

-2.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ERNA

Ernexa Therapeutics Inc. Common Stock

Ernexa Therapeutics Inc. Common Stock Profile